Lopend onderzoek en publicaties Urologie

Lopend onderzoek

• PRO-RCC
  National PROspective infrastructure for Renal Cell Carcinoma
• PSMA-Select
  Multi-institutional Evaluation of the Cost-effectiveness of PSMA-PET/CT for the Detection of Pelvic Lymph Node Invasion in Newly Diagnosed Prostate Cancer Patients
• Enforce
  Effectiveness of focal therapy in men with prostate cancer
• DOCTOR
  Duurzaamheid en doelmatigheid van CT diagnostiek in de follow-up van patiënten behandeld voor niet-spierinvasieve blaaskanker
• WINCLOVE Winq probiotica

Publicaties

• Effectiveness of preoperative chemotherapy and radical cystectomy in clinically node-positive and node-negative bladder cancer patients. (https://pubmed.ncbi.nlm.nih.gov/42001347/). Akand M, Van Weyenbergh T, Moris L, Muilwijk T, Bulteel S, Gajdos T, Van der Aa F, Everaerts W, Van Poppel H, Albersen M, Joniau S. World J Urol. 2025. doi: 10.1007/s00345-025-05991-w. PMID: 42001347.
   
• The significance of isolated de novo red patches in the bladder in patients referred with suspected urinary tract cancer: Results from the IDENTIFY study. (https://pubmed.ncbi.nlm.nih.gov/39877557/). Khadhouri S, Gallagher K, MacKenzie KR, Shah TT, Gao C, Zimmermann E, Mannas M, Lee T, Marra G, Gomez Rivas J, Marcq G, Assmus MA, Ucar T, Claps F, Boltri M, Pizzuto G, Burnhope T, Nkwam N, Tanasescu G, Boxall NE, Downey AP, Sukhu TA, Antón-Juanilla M, Rai S, Moore M, Bandeira de Mello K, Parsons S, McGrath JS, Kasivisvanathan V; IDENTIFY Study Group. Tim Muilwijk. BJUI Compass. 2025;6:e475. doi: 10.1002/bco2.475. PMID: 39877557; PMCID: PMC11771498.
   
• How Does Routine Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Modify the Current Management of Prostate Cancer? A Multidisciplinary View. (https://pubmed.ncbi.nlm.nih.gov/38706161/).
  Oprea-Lager DE, van Elst T, Aluwini S, Dewulf E, der Poel HV, Stoevelaar H, Bangma CH, Beeker A, Boudewijns S, Budiharto T, de Jong IJ, de Vries KC, Donswijk ML, Fütterer JJ, Hamberg P, Heijmen L, Hoekstra RJ, Kerkhofs TMA, Lavalaye J, de Bruin L, Noordzij W, Oving IM, Robbrecht DGJ, Schaake EE, van de Luijtgaarden ACM, van den Bergh RCN, van den Berkmortel F, van der Hulle T, van der Mijn JCK, van Dodewaard-de Jong JM, van Kruchten M, van Leeuwen PJ, van Limbergen E, van Moorselaar RJA, van Oort IM, van Roermund JGH, van Soest RJ, Veninga T, Vis AN, Voortman J, Willemse PM, Yakar D, Mehra N.
  Eur Urol Open Sci. 2025 May;75:69-79.
  doi: 10.1016/j.euros.2025.03.007. Epub 2025 Apr 7. PMID: 38706161
   
• Deciphering the molecular heterogeneity of intermediate- and (very-)high-risk non-muscle-invasive bladder cancer using multi-layered -omics studies https://pubmed.ncbi.nlm.nih.gov/39497708/ Murat Akand, Tatjana Jatsenko, Tim Muilwijk, Thomas Gevaert, Steven Joniau, Frank Van der Aa. PMID: 39497708 PMCID: PMC11532112 DOI: 10.3389/fonc.2024.1424293

• Prototol for the Prospective Sample Collection for Cancer of Bladder (ProCaB) Trial by the Cancer of the Bladder Leuven (CaBLe) Consortium https://pubmed.ncbi.nlm.nih.gov/39483518/ Murat Akand, Tim Muilwijk, Ben Van Cleynenbreugel, Thomas Gevaert, Steven Joniau, Frank Van der Aa. PMID: 39483518 PMCID: PMC11525467 DOI: 10.1016/j.euros.2024.09.006

• Fibroblast Activation Protein-α and the Immune Landscape: Unraveling T1 Non-muscle-invasive Bladder Cancer Progression https://pubmed.ncbi.nlm.nih.gov/39044944/  Tim Muilwijk, Loïc Baekelandt, Murat Akand, Sofie Daelemans, Koen Marien, Yannick Waumans, Pieter-Jan van Dam, Mark Kockx, Thomas Van den Broeck, Ben Van Cleynenbreugel, Frank Van der Aa, Thomas Gevaert, Steven Joniau  PMID: 39044944 PMCID: PMC11263494 DOI: 10.1016/j.euros.2024.06.011
   
• Risk of Cancer-related Death for Men with Biopsy Grade Group 1 Prostate Cancer and High-risk Features: A European Multi-institutional Study https://pubmed.ncbi.nlm.nih.gov/39040619/ Daimantas Milonas, Alexander Giesen, Tim Muilwijk, Charlotte Soenens, Gaëtan Devos, Zilvinas Venclovas, Alberto Briganti, Paolo Gontero, R Jeffrey Karnes, Piotr Chlosta, Frank Claessens, Gert De Meerleer, Wouter Everaerts, Markus Graefen, Giansilvio Marchioro, Rafael Sanchez-Salas, Bertrand Tombal, Henk Van Der Poel, Hendrik Van Poppel, Martin Spahn, Steven Joniau; European Multicenter Prostate Cancer Clinical and Translational (EMPaCT) Research Group 
  PMID: 39040619 PMCID: PMC11260856 DOI: 10.1016/j.euros.2024.06.001
  ​​​​​​​
• Validation of Claims Data for Absorbing Pads as a Measure for Urinary Incontinence after Radical Prostatectomy, a National Cross-Sectional Analysis. (https://pubmed.ncbi.nlm.nih.gov/38136286/). Baas DJH, Reitsma J, Gerwen LV, Vleghaar J, Gehlen JMLG, Ziedses des Plantes CMP, van Basten JPA, van den Bergh RCN, Bruins HM, Colette ERP, Hoekstra RJ, Knipscheer RJ, van Leeuwen PJ, Luijendijk-de Bruin D, van Roermund JGH, Sedelaar JPM, Speel TGW, Stomps SP, Wijburg CJ, Wijn RPWF, de Jong IJ, Somford DM. Cancers (Basel). 2023;15(24):5740. Published 2023 Dec 7. doi: 10.3390/cancers15245740
   
• Rectal Culture-Based Versus Empirical Antibiotic Prophylaxis to Prevent Infectious Complications in Men Undergoing Transrectal Prostate Biopsy: A Randomized, Nonblinded Multicenter Trial (https://pubmed.ncbi.nlm.nih.gov/36419331/). Tops SCM, Kolwijck E, Koldewijn EL, Somford DM, Delaere FJM, van Leeuwen MA, Breeuwsma AJ, de Vocht TF, Broos HJHP, Schipper RA, Steffens MG, Teerenstra S, Wegdam-Blans MCA, de Brauwer E, van den Bijllaardt W, Leenders ACAP, Sedelaar JPM, Wertheim HFL. Clin Infect Dis. 2023 Apr 3;76(7):1188-1196. doi: 10.1093/cid/ciac913.